News

World Alzheimer’s Day is a global effort to raise awareness and challenge the stigma around Alzheimer’s disease and other dementia. Do you know the differences between Alzheimer’s and dementia?
Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Alzheimer’s is one of several potential reasons for this decline, among them Frontotemporal Dementia, Huntington’s Disease, Parkinsons’s, or Vascular Dementia. Functional brain imaging is a cornerstone for the differentiation between all these different types of dementia and can support patient management as well as the research for potential therapies.
Perfusion imaging with Arterial Spin Labeling MRI has the potential to differentiate between Alzheimer’s and FTD but lacks standardization. In the ASPIRE project we develop an easy-to-use ASL evaluation tool that helps physicians to compare the brain perfusion pattern of a patient to a healthy control group. For more information visit aspire-mri.eu and alz.org.

Many thanks to Marylène Lejeune and Carlos López Pablo at Hospital Verge da la Cinta in Tortosa for hosting our PhD Candidate Yaqeen Ali for his first secondment within the BosomShield project. Yaqeen now knows a lot more about histopathologic imaging and will work on integrating these images into mTRIAL for AI-supported prediction of breast cancer relapse probability.

Click here for more information on this project: https://bosomshield.eu/

Thank you for attending our ASL-Dinner in Toronto, each and every one of you made it a great evening. In case you missed the presentation video, find it below. We are proud and happy to be an integral part of the #ismrm. The annual meeting offered again an interesting exchange on the latest trends in MR imaging.

Have you read one of the latest publications on iron rim lesions in multiple sclerosis by our research partners at the Universitätsmedizin Mannheim? The authors around Prof. Achim Gass conclude that iron rim lesions are associated with higher intrathecal immunoglobin G synthesis. Furthermore, CSF-mediated intrathecal smouldering inflammation could explain a CSF-related gradient of tissue damage.
Read the publication here.

Thank you for having us at the BosomShield kick off meeting. BosomShield is a project aiming a computer-aided design system for breast cancer classification and prognosis of relapse.
If you want to know further information about this project, visit bosomshield.eu.

Did you know that today is world clinical trials day? And did you know that mediri is working constantly to improve standardization of Arterial Spin Labeling MR Imaging for clinical trials? In the ASPIRE project (aspire-mri.eu) we are developing a web platform for easy and manufacturer independent analysis of ASL images for dementia diagnosis.
Want know more about this topic? Join us on ISMRM 2023 in Toronto and come to the ASL Dinner which is hosted by mediri GmbH and Gold Standard Phantoms.

Have you ever thought about assessing cerebral perfusion non-invasively in your next clinical trial? If so, this recently published review paper will address the most important questions such as how to equalize data acquisition across sites, how to perform QC and process the data. 
Read more here: https://lnkd.in/gE3Z8BKT

The implementation of ASL MRI for disease specific clinical cases has taken another milestone. Early 2023, a position paper supported by the ISMRM Perfusion Study Group updated and expanded the ASL MRI consensus paper from 2015 and provides guidance on using ASL MRI for clinical scenarios such as acute ischemic stroke, brain tumors and neurodegenerative diseases. 

Click here to read: https://lnkd.in/dvd7BCCv

ASL perfusion MRI permits non-invasive quantification of cerebral blood flow. The 2015 consensus paper on recommended implementation of ASL MRI established general guidelines for more comparable data acquisition and reproducible research. Mediri is happy to be part of this exciting journey.
Read more here: https://lnkd.in/eFXeQmi2

After a successful member audit we are excited to be a part of the Bundesverband Medizinischer Auftragsinstitute e.V. (BVMA). We are looking forward to our first general meeting in Cologne and the networking opportunities.
Want to know more about BVMA? Click here: https://www.bvma.de/